Grace Therapeutics, Inc. Cash Flow-to-Debt Ratio
Grace Therapeutics, Inc. cash flow-to-debt ratio. Grace Therapeutics, Inc. (GRCE) has a Cash Flow-to-Debt Ratio of -0.62x as of December 2025, meaning its operating cash flow of $-2.22 Million could theoretically repay -1% of its total liabilities ($3.60 Million) in one year. Check Grace Therapeutics, Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Grace Therapeutics, Inc. (2010–2025)
Cash flow-to-debt ratio of Grace Therapeutics, Inc. from 2010 to 2025. Historical debt coverage capacity for Grace Therapeutics, Inc. across 15 annual periods. Check Grace Therapeutics, Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Grace Therapeutics, Inc. Cash Flow-to-Debt Ratio by Year (2010–2025)
Grace Therapeutics, Inc. cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for Grace Therapeutics, Inc.. For the full cash flow conversion analysis, see Grace Therapeutics, Inc. (GRCE) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.77x | $-14.90 Million | $5.38 Million | ▼ -159.5% |
| 2024 | -1.07x | $-12.33 Million | $11.56 Million | ▲ +25.1% |
| 2023 | -1.42x | $-15.91 Million | $11.17 Million | ▼ -68.2% |
| 2022 | -0.85x | $-17.23 Million | $20.35 Million | ▲ +59.8% |
| 2021 | -2.11x | $-14.32 Million | $6.80 Million | ▲ +9.5% |
| 2020 | -2.33x | $-22.95 Million | $9.86 Million | ▼ -142.8% |
| 2019 | -0.96x | $-24.79 Million | $25.85 Million | ▼ -12.9% |
| 2018 | -0.85x | $-9.69 Million | $11.41 Million | ▲ +83.2% |
| 2016 | -5.07x | $-4.85 Million | $957.12K | ▼ -180.2% |
| 2015 | -1.81x | $-5.75 Million | $3.18 Million | ▼ -228.3% |
| 2014 | -0.55x | $-6.12 Million | $11.10 Million | ▲ +47.1% |
| 2013 | -1.04x | $-2.49 Million | $2.39 Million | ▲ +76.6% |
| 2012 | -4.46x | $-5.65 Million | $1.27 Million | ▼ -1120.5% |
| 2011 | -0.37x | $-1.91 Million | $5.24 Million | ▲ +6.2% |
| 2010 | -0.39x | $-1.90 Million | $4.88 Million | — |